资讯
A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...
But patients would rather treat their sleep apnea with tirzepatide (Zepbound), a GLP-1 weight-loss drug, researchers found. "The results highlight a need for real-world comparative effectiveness ...
Sleep Apnea Treatment Clash: Doctors prefer CPAP, but obese patients lean towards Zepbound. Explore this growing healthcare debate. MONDAY, June 9, 2025 ... Patients, Doctors Debate Sleep Apnea ...
The machines keep airways open using mild air pressure provided through a mask patients wear while sleeping. But patients would rather treat their sleep apnea with tirzepatide (Zepbound), a GLP-1 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果